PATENTS
Granted
- Lee, K.H.; Zhou, X.M.; Wang, Z.Q.; Chang, J.Y.; Chen, H.X.; Cheng, Y.C.; Shen, Y.C.; Han, F.S.; Hu, H., Zhang, Y.L. Etoposide analogs. US 5332811, Jul. 26, 1994 ~ Jul. 26, 2011.
- Cheng, C.T.; Chang, J.Y. TW0228417B, Sep. 27, 2002 ~ Sep. 26, 2022.
- Su T.L.; Chou, T.C.; Chang, J.Y. 5-(9-Acridinylamino)-Toluidine Compounds. US6821983B2, Jul. 30, 2003 ~ Jul. 29, 2023.
- Su, T.L., Chou, T.C.; Chang, J.Y. 5-(9-Acridinylamino)-Toluidine Compounds. ROC 1-246508, Jan. 1, 2006 ~ Dec. 13, 2023.
- Hsieh, H.P.; Liou, J.P.; Chang, J.Y.; Chang, C.W. “Indole Compounds as Inhibitors of Tubulin Polymerisation for the Treatment of Angiogenesis-related Disorders,” EP1506960, 2010
- Liou, J.P.; Chang, J.Y.; Hsieh, H.P. “Indoline-sulfonamides compounds”, US7741495, June 22, 2010 – August 31, 2027.
- Liou, J.P.; Chang, J.Y.; Hsieh, H.P. “Indoline-sulfonamides compounds”, 日本特許第4521428號, May 28, 2010 – August 31, 2027.
- Hsieh, H.P.; Liou, J.P.; Chang, J.Y.; Chang, C. W. “Indole Compounds,” US7632955, December 15, 2009 – December 12, 2022.
- Hsieh, H.P.; Liou, J.P.; Chang, J.Y.; Chang, C. W. “芳香羰吲哚化合物,” TWI317634, December 1, 2009 – December 11, 2022.
- Liou, J.P.; Chang, J.Y.; Hsieh, H.P. “Indoline-sulfonamides compounds”, TWI315304, October 1, 2009 – August 31, 2027.
- Liou, J.P.; Chang, J.Y.; Hsieh, H.P. “Indoline-sulfonamides compounds”, KR10-0916989, September 4, 2009 – August 31, 2027.
- Liou, J.P.; Chang, J.Y.; Hsieh, H.P. “Indoline-sulfonamides compounds”, AU2007214336, June 4, 2009 – August 31, 2027.
- Liou, J.P.; Chang, J.Y.; Hsieh, H.P. “Indoline-sulfonamides compounds”, GB2441396, May 13, 2009 – August 31, 2027.
- Hsieh, H.P.; Liou, J.P.; Chang, J.Y.; Chang, C.W. “Indole Compounds,” US7528165, May 5, 2009 – December 12, 2022.
- Hsieh, H.P.; Tung, Y.S.; Liou, J.P.; Chang, J.Y.; Chao, Y.S. “Anti-Tumor Compounds,” US7456289, November 25, 2008 – December 15, 2025.
- Liou, J.P.; Chang, J.Y.; Hsieh, H.P. “Indoline-sulfonamides compounds”, NZ561060, November 13, 2008 – August 31, 2027.
- Hsieh, H.P.; Tung, Y.S.; Liou, J.P. Chang, J.Y.; Chao, Y.S. “Anti-Tumor Compounds,” TWI296195, May 1, 2008 – December 27, 2025.
- Hsieh, H.P.; Liou, J.P.; Chang, J.Y.; Chang, C.W. “Indole Compounds,” US6933316, August 23, 2005 – December 12, 2022.
- Hsieh, H.P.; Chang, J.Y.; Kuo, C.C.; Chao, Y.S. “Coumarin Compounds and Their Use for Treating Cancer”, US8058427 B2, Nov. 15, 2011- June 10, 2029.
- Hsieh, H.P.; Chang, J.Y.; Kuo, C.C.; Chao, Y.S. “香豆素化合物及其治療癌症的用途”, 98119536, 98年6月11日, 中華民國
- 林俊成,陳若君,張文祥,汪炳鈞,謝興邦,張俊彥。“組織蛋白酶 S抑制劑”, I516479, 105年1月11日。(2016, 1/11-2030 12/2) 中華民國
- 沈孟儒,張廉筠,孫苑庭, 張俊彥。”建立分析模組快速分析神經功能的方法。”TWI547388號,中華民國 (2016/9/11至2034/9/23)
- Hsieh, H.P.; Chang JY, Kuo CC and Chao Y.治療癌症的醫藥組成物”. TW1415852, Nov. 21, 2013-June 11, 2029
- Lin CC, Chang WHW; Uang B.J., Chang, J.Y.; Hsieh, H.P. “ cathepsin S inhibitors” US8895497, Nov. 25, 2014-Dec. 2030
- Hsieh, H.P.; Liou, J.P., Chang, J.Y., Chang W. “Indole compounds.” CA2437104, March 2012-Aug. 13, 2023
- Hsieh, H.P.; Liou, J.P., Chang, J.Y., Chang W. “Indole compounds as inhibitors of tubulin polymerization for the treatment of angiogenesis-related disorders. “ EP15069 April.6, 2013-Aug. 7 2023